Teva Pharmaceutical Industries Ltd. (NYSE,TASE:TEVA) has signed an agreement to sell its Sellersville, Pennsylvania facility to G&W Laboratories, Inc., salvaging 280 employees’  jobs and further streamlining its own operations by reducing excess manufacturing capacity. The sale is part of the Company’s previously announced ...

Read More »